Updated:
Codman Neuro
Codman Neuro, a subsidiary of DePuy Synthes Companies of Johnson & Johnson, specializes in neurosurgery and neurovascular devices. Its portfolio includes...
Codman Neuro
Codman Neuro, a subsidiary of DePuy Synthes Companies of Johnson & Johnson, specializes in neurosurgery and neurovascular devices. Its portfolio includes products for hydrocephalus management, neuro intensive care, and cranial surgery. The company also offers aneurysm coils and vascular reconstruction devices for endovascular treatment of cerebral aneurysms and stroke.
General information
Firm type
Neurosurgery
Year founded
1838
Location
Region
North America
Country
United States
City
Raynham
Corporate office
Raynham, MA, United States
Sector focus
Frequently asked questions
What is Codman Neuro's primary business focus?
Codman Neuro develops and distributes medical devices for neurosurgery and neurovascular procedures, including shunt systems, microsurgical instruments, and cranial stabilization equipment. Its products serve hospitals and surgical centers worldwide (per public record).
Is Codman Neuro a standalone company or part of a larger organization?
Codman Neuro operates as a division within the DePuy Synthes franchise of Johnson & Johnson. It is not an independent investment vehicle but a product-focused business unit with its own operational strategy and sales infrastructure (per public record).
What is the history of the Codman brand?
The Codman brand was established by Codman & Shurtleff, a medical device company founded in 1838. It was acquired by Johnson & Johnson and integrated into the DePuy Synthes neurosurgery portfolio, maintaining the Codman Neuro name for neurospecific products (per public record).
Who competes with Codman Neuro in the neurosurgical device market?
Codman Neuro's primary competitors include Medtronic's neurosurgery division, Stryker's neurotechnology unit, and B. Braun's Aesculap brand. These firms also offer programmable shunt systems, cranial fixation devices, and microsurgical instruments (per public record).
Where are Codman Neuro's products used?
Codman Neuro devices are used in hospitals and surgical centers across North America, Europe, and parts of Asia-Pacific. The firm's sales and distribution network supports neurosurgeons and interventional neuroradiologists in clinical settings (per public record).
Does Codman Neuro function as an investor or asset manager?
No. Codman Neuro is a medical device operating division, not an investment firm. No AUM, fund structures, or capital deployment programs are associated with the entity (per public record).
What is Codman Neuro's regulatory history?
Codman Neuro products hold FDA approvals and CE markings for various neurosurgical devices. The firm's regulatory compliance is managed within Johnson & Johnson's broader quality systems framework (per public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: